相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Plant-derived vascular disrupting agents: compounds, actions, and clinical trials
Verena K. Kretzschmann et al.
PHYTOCHEMISTRY REVIEWS (2014)
Discovery and Hit to Lead Optimization of Novel Combretastatin A-4 Analogues: Dependence of C-Linker Length and Hybridization
Olivier Provot et al.
ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY (2013)
Structural Elaboration of a Natural Product: Identification of 3,3′-Diindolylmethane Aminophosphonate and Urea Derivatives as Potent Anticancer Agents
Somnath Kandekar et al.
CHEMMEDCHEM (2013)
Synthesis and Biological Evaluation of Imidazopyridine-Oxindole Conjugates as Microtubule-Targeting Agents
Ahmed Kamal et al.
CHEMMEDCHEM (2013)
Design of Combretastatin A-4 Analogs as Tubulin Targeted Vascular Disrupting Agent with Special Emphasis on Their Cis-Restricted Isomers
Harish Rajak et al.
CURRENT PHARMACEUTICAL DESIGN (2013)
Synthesis and biochemical activities of antiproliferative amino acid and phosphate derivatives of microtubule-disrupting β-lactam combretastatins
Niamh M. O'Boyle et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2013)
Design and Synthesis of Cyclopropylamide Analogues of Combretastatin-A4 as Novel Microtubule-Stabilizing Agents
Huan Chen et al.
JOURNAL OF MEDICINAL CHEMISTRY (2013)
Endowing Indole-Based Tubulin Inhibitors with an Anchor for Derivatization: Highly Potent 3-Substituted Indolephenstatins and Indoleisocombretastatins
Raquel Alvarez et al.
JOURNAL OF MEDICINAL CHEMISTRY (2013)
Synthesis of a 2-Aryl-3-aroyl Indole Salt (OXi8007) Resembling Combretastatin A-4 with Application as a Vascular Disrupting Agent
Mallinath B. Hadimani et al.
JOURNAL OF NATURAL PRODUCTS (2013)
Synthesis, biological evaluation, and structure-activity relationships of tri- and tetrasubstituted olefins related to isocombretastatin A-4 as new tubulin inhibitors
Jessy Aziz et al.
ORGANIC & BIOMOLECULAR CHEMISTRY (2013)
One-pot preparation of isocyanides from amines and their multicomponent reactions: crucial role of dehydrating agent and base
Sankar K. Guchhait et al.
RSC ADVANCES (2013)
Structural plasticity of tubulin assembly probed by vinca-domain ligands
Fanomezana M. Ranaivoson et al.
ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY (2012)
Novel cyanocombretastatins as potent tubulin polymerisation inhibitors
Pouria H. Jalily et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2012)
The Tubulin Colchicine Domain: a Molecular Modeling Perspective
Alberto Massarotti et al.
CHEMMEDCHEM (2012)
Synthesis and biological evaluation of combretastatin-amidobenzothiazole conjugates as potential anticancer agents
Ahmed Kamal et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2012)
Quinacrine has anticancer activity in breast cancer cells through inhibition of topoisomerase activity
Ranjan Preet et al.
INTERNATIONAL JOURNAL OF CANCER (2012)
Molecular Dynamics Investigation on a Series of HIV Protease Inhibitors: Assessing the Performance of MM-PBSA and MM-GBSA Approaches
Hemant Kumar Srivastava et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2012)
A chemoselective Ugi-type reaction in water using TMSCN as a functional isonitrile equivalent: generation of heteroaromatic molecular diversity
Sankar Kumar Guchhait et al.
ORGANIC & BIOMOLECULAR CHEMISTRY (2012)
B-Ring-Modified isoCombretastatin A-4 Analogues Endowed with Interesting Anticancer Activities
Abdallah Hamze et al.
CHEMMEDCHEM (2011)
Developments of Combretastatin A-4 Derivatives as Anticancer Agents
Y. Shan et al.
CURRENT MEDICINAL CHEMISTRY (2011)
Design, Synthesis, and SAR Studies of 4-Substituted Methoxylbenzoyl-aryl-thiazoles Analogues as Potent and Orally Bioavailable Anticancer Agents
Yan Lu et al.
JOURNAL OF MEDICINAL CHEMISTRY (2011)
N-Fused Imidazoles As Novel Anticancer Agents That Inhibit Catalytic Activity of Topoisomerase IIα and Induce Apoptosis in G1/S Phase
Ashish T. Baviskar et al.
JOURNAL OF MEDICINAL CHEMISTRY (2011)
5-Fluorouracil Increases the Chemopreventive Potentials of Resveratrol Through DNA Damage and MAPK Signaling Pathway in Human Colorectal Cancer Cells
Purusottam Mohapatra et al.
ONCOLOGY RESEARCH (2011)
Design and pharmacophore modeling of biaryl methyl eugenol analogs as breast cancer invasion inhibitors
Fatma M. Abdel Bar et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2010)
Structure-based virtual screening of novel tubulin inhibitors and their characterization as anti-mitotic agents
Nam Doo Kim et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2010)
Disrupting Established Tumor Blood Vessels An Emerging Therapeutic Strategy for Cancer
Mark J. McKeage et al.
CANCER (2010)
From signaling pathways to microtubule dynamics: the key players
Sandrine Etienne-Manneville
CURRENT OPINION IN CELL BIOLOGY (2010)
Combretastatin A4 phosphate: a novel vascular disrupting agent
Govardhanan Nagaiah et al.
FUTURE ONCOLOGY (2010)
Synthesis and Discovery of Water-Soluble Microtubule Targeting Agents that Bind to the Colchicine Site on Tubulin and Circumvent Pgp Mediated Resistance
Aleem Gangjee et al.
JOURNAL OF MEDICINAL CHEMISTRY (2010)
Towards molecular diversity: dealkylation of tert-butyl amine in Ugi-type multicomponent reaction product establishes tert-butyl isocyanide as a useful convertible isonitrile
Sankar K. Guchhait et al.
ORGANIC & BIOMOLECULAR CHEMISTRY (2010)
Design, synthesis and biological evaluation of imidazopyridine/pyrimidine-chalcone derivatives as potential anticancer agents
Ahmed Kamal et al.
MEDCHEMCOMM (2010)
Combretastatin-like chalcones as inhibitors of microtubule polymerisation. Part 2: Structure-based discovery of alpha-aryl chalcones
Sylvie Ducki et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2009)
Antivascular Actions of Microtubule-Binding Drugs
Edward L. Schwartz
CLINICAL CANCER RESEARCH (2009)
AVE8062: a new combretastatin derivative vascular disrupting agent
Angelo Delmonte et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2009)
Integration of Ligand and Structure-Based Virtual Screening for the Identification of the First Dual Targeting Agent for Heat Shock Protein 90 (Hsp90) and Tubulin
Andrew J. S. Knox et al.
JOURNAL OF MEDICINAL CHEMISTRY (2009)
Recent Development and SAR Analysis of Colchicine Binding Site Inhibitors
Jing Chen et al.
MINI-REVIEWS IN MEDICINAL CHEMISTRY (2009)
Variations in the colchicine-binding domain provide insight into the structural switch of tubulin
Audrey Dorleans et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
An Efficient, Regioselective, Versatile Synthesis of N-Fused 2-and 3-Aminoimidazoles via Ugi-Type Multicomponent Reaction Mediated by Zirconium(IV) Chloride in Polyethylene Glycol-400
Sankar K. Guchhait et al.
SYNLETT (2009)
A Highly Flexible and Efficient Ugi-Type Multicomponent Synthesis of Versatile N-Fused Aminoimidazoles
Sankar K. Guchhait et al.
SYNTHESIS-STUTTGART (2009)
1,5-disubstituted 1,2,3-triazoles as cis-restricted analogues of combretastatin A-4:: Synthesis, molecular modeling and evaluation as cytotoxic agents and inhibitors of tubulin
Kristin Odlo et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2008)
Tumour vascular disrupting agents: combating treatment resistance
G. M. Tozer et al.
BRITISH JOURNAL OF RADIOLOGY (2008)
In vitro metabolism study of combretastatin A-4 in rat and human liver Microsomes
Silvio Aprile et al.
DRUG METABOLISM AND DISPOSITION (2007)
Combretastatin a-4 analogs as anticancer agents
Anurag Chaudhary et al.
MINI-REVIEWS IN MEDICINAL CHEMISTRY (2007)
Arylthioindole inhibitors of tubulin polymerization.: 3.: Biological evaluation, structure-activity relationships and molecular modeling studies
Giuseppe La Regina et al.
JOURNAL OF MEDICINAL CHEMISTRY (2007)
Vascular disrupting agents in clinical development
P. Hinnen et al.
BRITISH JOURNAL OF CANCER (2007)
Vascular disrupting agents
John W. Lippert
BIOORGANIC & MEDICINAL CHEMISTRY (2007)
Cytokinesis-block micronucleus cytome assay
Michael Fenech
NATURE PROTOCOLS (2007)
Comparison of multiple amber force fields and development of improved protein backbone parameters
Viktor Hornak et al.
PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS (2006)
Novel imidazole-based combretastatin A-4 analogues: Evaluation of their in vitro antitumor activity and molecular modeling study of their binding to the colchicine site of tubulin
Fabio Bellina et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2006)
Automatic atom type and bond type perception in molecular mechanical calculations
Junmei Wang et al.
JOURNAL OF MOLECULAR GRAPHICS & MODELLING (2006)
Interaction of 4-arylcoumarin analogues of combretastatins with microtubule network of HBL100 cells and binding to tubulin
Catherine Rappl et al.
BIOCHEMISTRY (2006)
Novel combretastatin analogues endowed with antitumor activity
Daniele Simoni et al.
JOURNAL OF MEDICINAL CHEMISTRY (2006)
New arylthioindoles: Potent inhibitors of tubulin polymerization. 2. Structure-activity relationships and molecular modeling studies
G De Martino et al.
JOURNAL OF MEDICINAL CHEMISTRY (2006)
Medicinal chemistry of combretastatin A4: Present and future directions
GC Tron et al.
JOURNAL OF MEDICINAL CHEMISTRY (2006)
A common pharmacophore for a diverse set of colchicine site inhibitors using a structure-based approach
TL Nguyen et al.
JOURNAL OF MEDICINAL CHEMISTRY (2005)
Antineoplastic agents. 445. Synthesis and evaluation of structural modifications of (Z)- and (E)-combretastatin A-4
GR Pettit et al.
JOURNAL OF MEDICINAL CHEMISTRY (2005)
Further naphthylcombretastatins.: An investigation on the role of the naphthalene moiety
ABS Maya et al.
JOURNAL OF MEDICINAL CHEMISTRY (2005)
Review: Tubulin function, action of antitubulin drugs, and new drug development
F Pellegrini et al.
CANCER INVESTIGATION (2005)
Microtubules as a target for anticancer drugs
MA Jordan et al.
NATURE REVIEWS CANCER (2004)
Glide: A new approach for rapid, accurate docking and scoring. 1. Method and assessment of docking accuracy
RA Friesner et al.
JOURNAL OF MEDICINAL CHEMISTRY (2004)
Insight into tubulin regulation from a complex with colchicine and a stathmin-like domain
RBG Ravelli et al.
NATURE (2004)
A tale of two tumor targets: Topoisomerase I and tubulin. The Wall and Wani contribution to cancer chemotherapy
GM Cragg et al.
JOURNAL OF NATURAL PRODUCTS (2004)
Development and testing of a general amber force field
JM Wang et al.
JOURNAL OF COMPUTATIONAL CHEMISTRY (2004)
Combretastatins: from natural products to drug discovery
A Cirla et al.
NATURAL PRODUCT REPORTS (2003)
Combretastatin A-4 analogues as antimitotic antitumor agents
NH Nam
CURRENT MEDICINAL CHEMISTRY (2003)
Discovery and development of antimitotic agents that inhibit tubulin polymerisation for the treatment of cancer
Q Li et al.
EXPERT OPINION ON THERAPEUTIC PATENTS (2002)
One-pot synthesis of benzo[b]furan and indole inhibitors of tubulin polymerization
BL Flynn et al.
JOURNAL OF MEDICINAL CHEMISTRY (2002)
Potent, orally active heterocycle-based combretastatin A-4 analogues: Synthesis, structure-activity relationship, pharmacokinetics, and in vivo antitumor activity evaluation
L Wang et al.
JOURNAL OF MEDICINAL CHEMISTRY (2002)
Anticancer therapy with novel tubulin-interacting drugs
M Kavallaris et al.
DRUG RESISTANCE UPDATES (2001)
The synthesis and tubulin binding activity of thiophene-based analogues of combretastatin A-4
BL Flynn et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2001)
Calculating structures and free energies of complex molecules: Combining molecular mechanics and continuum models
PA Kollman et al.
ACCOUNTS OF CHEMICAL RESEARCH (2000)
Synthesis and biological evaluation of aryl azide derivatives of combretastatin A-4 as molecular probes for tubulin
KG Pinney et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2000)
Antineoplastic agents 440.: Asymmetric synthesis and evaluation of the combretastatin A-1 SAR probes (1S,2S)- and (1R,2R)-1,2-dihydroxy-1-(2′,3′-dihydroxy-4′-methoxyphenyl)-2-(3,4,5-trimethoxyphenyl)-ethane
GR Pettit et al.
JOURNAL OF NATURAL PRODUCTS (2000)
分享论文
